387 related articles for article (PubMed ID: 36902253)
21. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer.
Sundar IK; Rahman I
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1245-L1258. PubMed ID: 27793800
[TBL] [Abstract][Full Text] [Related]
23. Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.
Suchanti S; Stephen BJ; Awasthi S; Awasthi SK; Singh G; Singh A; Mishra R
Epigenomics; 2022 Mar; 14(5):279-293. PubMed ID: 35184601
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of epithelial to mesenchymal transition.
Huangyang P; Shang Y
Curr Cancer Drug Targets; 2013 Nov; 13(9):973-85. PubMed ID: 24168185
[TBL] [Abstract][Full Text] [Related]
25. The epigenetics of epithelial-mesenchymal plasticity in cancer.
Tam WL; Weinberg RA
Nat Med; 2013 Nov; 19(11):1438-49. PubMed ID: 24202396
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma.
Syren P; Andersson R; Bauden M; Ansari D
Scand J Gastroenterol; 2017; 52(6-7):668-673. PubMed ID: 28301276
[TBL] [Abstract][Full Text] [Related]
27. SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer.
Viotti M; Wilson C; McCleland M; Koeppen H; Haley B; Jhunjhunwala S; Klijn C; Modrusan Z; Arnott D; Classon M; Stephan JP; Mellman I
J Cell Biol; 2018 Feb; 217(2):763-777. PubMed ID: 29229751
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms and importance of histone modification enzymes in targeted therapy for hepatobiliary cancers.
Fu W; Gao L; Huang C; Yao J; Lin Y; Bai B; Yue P; Liu Y; Meng W; Qiao L; Li X
Discov Med; 2019 Jul; 28(151):17-28. PubMed ID: 31465722
[TBL] [Abstract][Full Text] [Related]
29. Impaired histone inheritance promotes tumor progression.
Tian C; Zhou J; Li X; Gao Y; Wen Q; Kang X; Wang N; Yao Y; Jiang J; Song G; Zhang T; Hu S; Liao J; Yu C; Wang Z; Liu X; Pei X; Chan K; Liu Z; Gan H
Nat Commun; 2023 Jun; 14(1):3429. PubMed ID: 37301892
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
[TBL] [Abstract][Full Text] [Related]
31. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
32. KDM4B promotes epithelial-mesenchymal transition through up-regulation of ZEB1 in pancreatic cancer.
Li S; Wu L; Wang Q; Li Y; Wang X
Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):997-1004. PubMed ID: 26511091
[TBL] [Abstract][Full Text] [Related]
33. Histone Modifications and their Role in Epigenetics of Cancer.
Zaib S; Rana N; Khan I
Curr Med Chem; 2022; 29(14):2399-2411. PubMed ID: 34749606
[TBL] [Abstract][Full Text] [Related]
34. HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.
Watanabe S; Ueda Y; Akaboshi S; Hino Y; Sekita Y; Nakao M
Am J Pathol; 2009 Mar; 174(3):854-68. PubMed ID: 19179606
[TBL] [Abstract][Full Text] [Related]
35. Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.
Manuyakorn A; Paulus R; Farrell J; Dawson NA; Tze S; Cheung-Lau G; Hines OJ; Reber H; Seligson DB; Horvath S; Kurdistani SK; Guha C; Dawson DW
J Clin Oncol; 2010 Mar; 28(8):1358-65. PubMed ID: 20142597
[TBL] [Abstract][Full Text] [Related]
36. Targeting Histone Onco- Modifications Using Plant-Derived Products.
Illam SP; Kandiyil SP; Raghavamenon AC
Curr Drug Targets; 2021; 22(11):1317-1331. PubMed ID: 33461463
[TBL] [Abstract][Full Text] [Related]
37. Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?
Jiang JH; Liu C; Cheng H; Lu Y; Qin Y; Xu YF; Xu J; Long J; Liu L; Ni QX; Yu XJ
Biochim Biophys Acta; 2015 Jan; 1855(1):43-9. PubMed ID: 25432020
[TBL] [Abstract][Full Text] [Related]
38. The histone code of Toxoplasma gondii comprises conserved and unique posttranslational modifications.
Nardelli SC; Che FY; Silmon de Monerri NC; Xiao H; Nieves E; Madrid-Aliste C; Angel SO; Sullivan WJ; Angeletti RH; Kim K; Weiss LM
mBio; 2013 Dec; 4(6):e00922-13. PubMed ID: 24327343
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Gene Expression by Sodium Valproate in Epithelial-to-Mesenchymal Transition.
Noguchi S; Eitoku M; Moriya S; Kondo S; Kiyosawa H; Watanabe T; Suganuma N
Lung; 2015 Oct; 193(5):691-700. PubMed ID: 26286207
[TBL] [Abstract][Full Text] [Related]
40. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.
Serrano-Gomez SJ; Maziveyi M; Alahari SK
Mol Cancer; 2016 Feb; 15():18. PubMed ID: 26905733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
